The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Gene Review

Ts3  -  Trichinella spiralis resistance 3

Mus musculus

Synonyms: Ts-3
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Ts3

  • The genetic restrictions of the activation of third-order suppressor cells (Ts3) were studied in mice, using two different types of anti-azobenzenearsonate (ABA)-immune responses, namely delayed-type hypersensitivity (DTH) and cytotoxic T lymphocyte (CTL) generation [1].
  • Therefore, macrophages derived from Early or Late schistosome granulomas or normal spleens are apparently phenotypically indistinguishable and equally capable, in extremely small quantities, of inducing NP-specific DTH, Ts1, and Ts3 immune responses [2].
  • We evaluated the ability of these hybridomas to induce third order or effector Ts (Ts3) to suppress the contact sensitivity response against the hapten 4-hydroxy-3-nitrophenyl acetyl (NP) [3].
 

High impact information on Ts3

  • The Ts3 subset of suppressor cells is generated after antigen priming, but, in order to express suppressor activity these cells require an additional activation step involving triggering with specific suppressor factors (TsF2) [4].
  • This report characterizes two cloned hybridoma cell lines (pTs3 hybridomas) that represent this stage of Ts3 cell differentiation [4].
  • First, heterogeneous populations of F1 Ts3 cells were activated in vitro and then assayed in Ts3-depleted recipients which carried different combinations of H-2 and Igh alleles [5].
  • We have found that an I-J+ I-A- antigen-presenting cell (APC) is required for Ts3 activation in vivo [6].
  • This selective activation of Ts3 suggested the existence of I-J-related antigen presentation for suppression as the counterpart of I-A or I-A-I-E-restricted antigen presentation for positive immune responses [1].
 

Chemical compound and disease context of Ts3

  • In contrast to the parental P388D1 and two other macrophage hybridomas, one macrophage hybridoma clone, termed 63, when conjugated with NP, induced Ts3, which suppressed contact sensitivity responses against NP but not DNFB, showing that the Ts3 were antigen specific [3].
  • The suppressive potential was then tested in mice previously primed for delayed-type hypersensitivity responses which were also treated with cyclophosphamide to deplete Ts3 and other drug-sensitive Ts cell types [7].
 

Biological context of Ts3

  • Since the mode of induction and the phenotype of the third C. neoformans-specific suppressor cells are similar to those reported for Ts3 cells in other antigen-specific suppression models, we referred to this third suppressor cell in the C. neoformans-specific suppressor cell cascade as a Ts3 cell [8].
  • Although H-2-linked Ir genes control the development of helper T cells and hapten-specific B cells, they do not influence Ts3 generation [9].
  • As suggested by our previous studies on lymphokine production, the results obtained were consistent with direct impairment of Th-cell function and/or with tumour-induced suppression of cell-mediated immunity by Cy-insensitive suppressor cells, such as the 'Ts effector' (Ts3) or those of non-T-cell lineage [10].
 

Anatomical context of Ts3

  • The involvement of a third-order suppressor T cell population (Ts3) in the suppression of in vitro PFC responses was analyzed [11].
  • These results are discussed with respect to T cell-mediated suppression in other murine tumor systems and the possible pivotal role for a tumor antigen-presenting cell in activating Ts3 in the S1509a tumor system [12].
  • No age restriction was found for antigen presentation to Ts1 cells and for the interaction between Ts3 cells and target B cells [13].
  • The data demonstrate that Ts3 induction is independent of the carrier requirements involved in helper T cell induction and is not dependent upon B cell priming [9].
  • Anti-IJ mAb blocked Ts3 activation at the lymphocyte level whereas anti-IJ idiotype blocked activation at the accessory cell level [14].
 

Associations of Ts3 with chemical compounds

 

Other interactions of Ts3

  • These three populations, termed Ts1, Ts2, and Ts3 have been characterized to have inducer, transducer and effector functions, respectively [15].
  • It appears that antigen-activated CRI+ Ts3 require signals from the anti-CRI Ts2 subset to suppress DTH reactions in an idiotype-nonspecific manner [16].
  • In contrast, the target of the Igh-V restriction of TsF2 appears to be the Ts3 cell, which carries antigen-specific, idiotype-related receptors [17].
  • The present report analyzes the specificity of NP-specific Ts3 cells and factors derived from H-2 and Igh heterozygous (B6 X C3H)F1 mice [5].
 

Analytical, diagnostic and therapeutic context of Ts3

References

  1. I-J-restricted interactions in the generation of azobenzenearsonate-specific suppressor T cells. Takaoki, M., Sy, M.S., Tominaga, A., Lowy, A., Tsurufuji, M., Finberg, R., Benacerraf, B., Greene, M.I. J. Exp. Med. (1982) [Pubmed]
  2. Induction of immune responses by schistosome granuloma macrophages. Sunday, M.E., Stadecker, M.J., Wright, J.A., Aoki, I., Dorf, M.E. J. Immunol. (1983) [Pubmed]
  3. Functional analysis of cloned macrophage hybridomas. V. Induction of suppressor T cell responses. Kawasaki, H., Martin, C.A., Uchida, T., Usui, M., Noma, T., Minami, M., Dorf, M.E. J. Immunol. (1986) [Pubmed]
  4. Analysis of T cell hybridomas. IV. Characterization of inducible suppressor cell hybridomas. Minami, M., Okuda, K., Furusawa, S., Dorf, M.E. J. Exp. Med. (1983) [Pubmed]
  5. The role of I-J and Igh determinants on F1-derived suppressor factor in controlling restriction specificity. Minami, M., Aoki, I., Honji, N., Waltenbaugh, C.R., Dorf, M.E. J. Exp. Med. (1983) [Pubmed]
  6. Identification of an I-J+ antigen-presenting cell required for third order suppressor cell activation. Lowy, A., Tominaga, A., Drebin, J.A., Takaoki, M., Benacerraf, B., Greene, M.I. J. Exp. Med. (1983) [Pubmed]
  7. Interaction of idiotype-specific T suppressor factor with the hapten-specific third-order T suppressor subset results in antigen-nonspecific suppression. Jayaraman, S., Bellone, C.J. Cell. Immunol. (1986) [Pubmed]
  8. Characterization of a third-order suppressor T cell (Ts3) induced by cryptococcal antigen(s). Khakpour, F.R., Murphy, J.W. Infect. Immun. (1987) [Pubmed]
  9. Hapten-specific T cell responses to 4-hydroxy-3-nitrophenyl acetyl. XIV. Carrier requirement for suppressor cell induction. Sherr, D.H., Vietor, H.E., Liu, Y.N., Dorf, M.E. J. Immunol. (1984) [Pubmed]
  10. Cancer-induced alterations in T-cell subsets in normal and cyclophosphamide-treated mice. A flow cytometric analysis. Tonner, E., Sewell, H.F., Thomson, A.W. Int. Arch. Allergy Appl. Immunol. (1988) [Pubmed]
  11. Hapten-specific T cell responses to 4-hydroxy-3-nitrophenyl acetyl. XIII. Characterization of a third T cell population involved in suppression of in vitro PFC responses. Sherr, D.H., Dorf, M.E. J. Immunol. (1982) [Pubmed]
  12. Regulation of the immune response to tumor antigens. X. Activation of third-order suppressor T cells that abrogate anti-tumor immune responses. Schatten, S., Drebin, J.A., Perry, L.L., Chung, W., Greene, M.I. J. Immunol. (1984) [Pubmed]
  13. Age-related changes within a suppressor T cell circuit. Doria, G., Mancini, C., Frasca, D. Cell. Immunol. (1989) [Pubmed]
  14. Requirements for suppressor cell activation. Role of accessory cells. Kuchroo, V.K., Minami, M., Diamond, B., Dorf, M.E. J. Immunol. (1989) [Pubmed]
  15. In vitro generation of suppressor T cells. Induction of CD3+, IgH-restricted suppressor cells. O'Hara, R.M., Sherr, D.H., Dorf, M.E. J. Immunol. (1988) [Pubmed]
  16. Antigen- and receptor-driven regulatory mechanisms. VIII. Suppression of idiotype-negative, p-azobenzenearsonate-specific T cells results from the interaction of an anti-idiotypic second-order T suppressor cell with a cross-reactive-idiotype-positive, p-azobenzenearsonate-primed T cell target. Sy, M.S., Nisonoff, A., Germain, R.N., Benacerraf, B., Greene, M.I. J. Exp. Med. (1981) [Pubmed]
  17. Requirements for suppressor T cell activation. Usui, M., Aoki, I., Sunshine, G.H., Dorf, M.E. J. Immunol. (1984) [Pubmed]
  18. A monoclonal antibody raised to tumor-specific T cell-derived suppressor factors also recognizes T suppressor inducer factors of the 4-hydroxy-3-nitrophenyl acetyl hapten suppressor network. Steele, J.K., Kawasaki, H., Kuchroo, V.K., Minami, M., Levy, J.G., Dorf, M.E. J. Immunol. (1987) [Pubmed]
 
WikiGenes - Universities